Letter: Diabetogenic drugs.
D001581:Benzothiadiazines; D003920:Diabetes Mellitus / Q000139:chemically induced*; D004232:Diuretics; D006801:Humans; D007328:Insulin / Q000378:metabolism; D007329:Insulin Antagonists; D000078790:Insulin Secretion; D008775:Methylprednisolone / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects*; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects*
D001581:Benzothiadiazines; D004232:Diuretics; D007328:Insulin; D007329:Insulin Antagonists; D049993:Sodium Chloride Symporter Inhibitors; D010672:Phenytoin; D008775:Methylprednisolone